Suchen
Nanobiotix SA
NBTXZur Watchlist hinzufügen
39.480USD
+1.780+4.72%
Handelsschluss 07/01, 16:00（ET）Kurse um 15 Minuten verzögert
1.92BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Nanobiotix SA Unternehmen
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Nanobiotix SA Informationen
BörsenkürzelNBTX
Name des UnternehmensNanobiotix SA
IPO-datumOct 29, 2012
CEOLevy (Laurent)
Anzahl der mitarbeiter108
WertpapierartDepository Receipt
GeschäftsjahresendeOct 29
Addresse60 rue de Wattignies
StadtPARIS
BörseNASDAQ OMX - NASDAQ BASIC
LandFrance
Postleitzahl75012
Telefon33140260470
Websitehttps://www.nanobiotix.com
BörsenkürzelNBTX
IPO-datumOct 29, 2012
CEOLevy (Laurent)
Führungskräfte von Nanobiotix SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Ms. Anne-Sophie Lariviere
Ms. Anne-Sophie Lariviere
Vice President - Strategy & Operational Excellence
Vice President - Strategy & Operational Excellence
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Director
Independent Director
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the of the Board
Independent Vice Chairwoman of the of the Board
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Director
Independent Director
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial & Business Officer
Chief Financial & Business Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Nanobiotix SA?
Die fünf größten Anteilseigner von Nanobiotix SA sind: Dr. Laurent Levy, Ph.D.
Wie viele Institutionen halten Anteile an Nanobiotix SA (NBTX)?
Mit Stand vom 2026Q1 halten 30 Institutionen Anteile an Nanobiotix SA, mit einem Gesamtmarktwert von etwa 5.71M, was 11.79% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -3044728.00 gestiegen.